Jorda Radek

Journals

MORADI, M., A. MOUSAVI, E. ŘEZNÍČKOVÁ, F. PEYTAM, M. PERINA, V. VOJÁČKOVÁ, L. FIROOZPOUR, R. JORDA, J. GRÚZ, Z. EMAMGHOLIPOUR, S. SADAT-EBRAHIMI, V. KRYŠTOF, A. FOROUMADI
Identification of furo[2,3-d]pyrimidin-4-ylsulfanyl-1,3,4-thiadiazole derivatives as novel FLT3-ITD inhibitors. European Journal of Medicinal Chemistry. 2024, ISSN: 0223-5234, PMID: 39427515,  PDF.
DELGADO, T., V. D., H. DOSTÁLOVÁ, V. KRYŠTOF, V. VOJÁČKOVÁ, R. JORDA, A. CASTRO, J. BERTRAND, G. RIVERA, M. FAUNDEZ, M. STRNAD, C. ESPINOSA-BUSTOS, O. SALAS C.
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics. 2024, 16(5), 649, ISSN: 1999-4923, PMID: 38794311,  PDF.
KOVALOVA, M., J. BARAKA, V. MIK, R. JORDA, M. LUO, H. SHAO, V. KRYŠTOF
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opinion on Therapeutic Patents. 2023, 33(2), 67-87, ISSN: 1354-3776, PMID: 36975020,  PDF.